Chew Weed Everyday: Axim Biotech Produces Cannabinoid Chewing Gum

AXIM Biotechnologies (OTC:AXIM), developers of cannabinoid-based pharmaceutical and cosmetic products, announced the production of CanChew Plus.

CanChew Plus is an upgrade from AXIM's original CanChew, which the company calls "the most well-known cannabis gum product on the market." While the fate of recreational marijuana use has come into question, marijuana stocks as a whole have been on a high in 2017.

Features of CanChew Plus, which is currently in a clinical trial in the Netherlands for the treatment of irritable bowel syndrome, include:

• Non-habit forming
• No prescription needed
• Available in all 50 states
• Comes in a delicious new spearmint flavor
• Great-tasting mint gum has no artificial sweeteners or preservatives
• Non-GMO, gluten free, vegan and kosher

In a press release, AXIM says CanChew Plus contains the same active ingredients and is designed to be 60% smaller than the original CanChew.

Shares of AXIM were down 5.64 percent Wednesday.